|
|
OCTREOTIDE 0.1MG/ML INJ (DIL/AHI)
|
|
|
|
|
|
9292
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
Symptomatic management of neuroendocrine tumours.
|
|
|
Anorexia, nausea, vomiting, diarrhoea and steatorrhoea, abdominal discomfort, and flatulence.
|
|
|
Initially 50 micrograms 1–2 times a day , adjusted according to resp onse; increased to 200 micrograms 3 times a day.
|
|
|
|
|
|
|
|
|
|
|
|
|